BioUtah News
-
CivicaScript® launches low-cost treatment to improve walking for people with multiple sclerosis
CivicaScript®, LLC, a nonprofit company dedicated to bringing low-cost generic medicines to U.S. patients, today announced the availability…
-
HUNTSMAN MENTAL HEALTH INSTITUTE CELEBRATES 10 YEARS OF BEHAVIORAL HEALTH INTEGRATION PROGRAM
The groundbreaking care model expanded from 5 to 15+ clinic locations to achieve 15% patient penetration rate, exceeding…
-
SINTX Technologies Issues Business Update Following Strategic Realignment, Leadership Expansion, and SiNAPTIC Acquisition
SALT LAKE CITY, Utah, Aug. 15, 2025 (GLOBE NEWSWIRE) — SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the…
-
First Patient Enrolled in Merit Medical’s WRAPSODY (WRAP) North America Registry
The WRAP North America registry is a prospective, multicenter study designed to collect real-world safety and effectiveness data…
-
Shedding Light On Cardiac Repair: How Red-Light Preconditioning Improves Cell Therapy
Following a heart attack, fibrosis is the primary obstacle to recovery. Healthy heart muscle is replaced with non-functional…
-
Owlet® Achieves TGA Certification for Dream Sock™, Paving the Way for Launch in Australia and New Zealand
Certification underscores Owlet’s commitment to bringing medically-certified infant monitoring technology to every family across the globe. LEHI, Utah–(BUSINESS…
-
bioMérieux receives U.S. FDA 510(k) clearance and CLIA-waiver for Anterior Nasal Swab specimens, an additional sample type for use with the BIOFIRE® SPOTFIRE® R/ST Panel Mini
Marcy-l’Étoile (France), August 18, 2025 – bioMérieux, a world leader in the field of in vitro diagnostics, today…
-
Nusano Cuts Ribbon on State-of-the-Art Radioisotope Production Facility
WEST VALLEY CITY, Utah – Aug. 21, 2025 – Nusano, a physics company transforming the production of radioisotopes,…
-
Sethera Therapeutics Unveils Breakthrough Enzymatic Platform for Next-Generation Peptide Drugs
SALT LAKE CITY, Utah August 21, 2025 — Sethera Therapeutics today announced publication in the Proceedings of the…
-
Intermountain Health Announces New Children’s Health President and Expands Leadership Role for Hospital President to Build on Legacy of Pediatric Excellence
Intermountain Health Announces New Children’s Health President and Expands Leadership Role for Hospital President to Build on Legacy…
-
Seek Labs Unveils BioSeeker™
Bioseeker™ is the AI Discovery Engine Powering Seek Labs’ Mission to Outpace Disease with Faster, Smarter Global Health…
-
Merit Medical Launches the Prelude Wave Hydrophilic Sheath Introducer with SnapFix Technology
Thin-wall design with superior insertion and unique sheath-securement solution to support successful radial access procedures and may aid…
-
Purgo Scientific Appoints Veteran MedTech Leader as Chief Executive Officer
James A. Bowman brings decades of experience launching disruptive surgical innovations.
-
Quansys Biosciences Launches Q-View™ Imager Plus: Delivering Reproducible, high-impact ELISA Data with Ease
Quansys Biosciences Launches Q-View™ Imager Plus: Delivering Reproducible, high-impact ELISA Data with Ease
-
Improving Women’s Health: MobileODT Joins Liger Medical
Improving Women’s Health: MobileODT Joins Liger Medical
-
Wasatch Health Announces Structured Capital Fund
Utah Investment Firm Expands to Deliver Flexible Capital to Transformative Healthcare Companies
-
Seek Labs Announces Inclusion of Veterinary Diseases in Global Disease Atlas, Accelerating Development of Therapeutics to Bolster Global Protein Supply Chains
Accelerating Development of Therapeutics to Bolster Global Protein Supply Chains
-
Nestmedic Selects Curavit Clinical Research as U.S. CRO Partner for Pioneering Prenatal Monitoring Trial
Nestmedic Selects Curavit Clinical Research as U.S. CRO Partner for Pioneering Prenatal Monitoring Trial
-
Microvascular Therapeutics Celebrates Major Achievements at ASE 2025 Scientific Sessions
Microvascular Therapeutics Celebrates Major Achievements at ASE 2025 Scientific Sessions
-
BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV)
BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV)
-
Canary Speech Achieves HITRUST e1 Certification for Voice Biomarker Platform
Canary Speech announces it has obtained HITRUST e1 Certification, reinforcing its commitment to cybersecurity related to its voice…
-
Recursion Acquires Full Rights to REV102, a Potential First-in-Class Oral ENPP1 Inhibitor for Hypophosphatasia
Recursion Acquires Full Rights to REV102, a Potential First-in-Class Oral ENPP1 Inhibitor for Hypophosphatasia
-
GE HealthCare’s Economic Impact Across Utah
GE HealthCare’s Economic Impact Across Utah
-
RefloDx Wins Trans Atlantic Angel Grand Prize
RefloDx Wins Trans Atlantic Angel Grand Prize.
-
bioMérieux strengthens its next-generation sequencing capabilities with the acquisition of Day Zero Diagnostics solutions and technologies
bioMérieux strengthens its next-generation sequencing capabilities with the acquisition of Day Zero Diagnostics solutions and technologies
-
DGENTHERA AND NUSANO SIGN LETTER OF INTENT FOR ASTATINE‑211 SUPPLY
ALPHA-EMITTING RADIOISOTOPE EXPECTED TO PLAY AN ESSENTIAL ROLE IN NEXT-GENERATION TARGETED CANCER THERAPIES
-
Halia Therapeutics Completes First-in-Human Phase 1 Study of HT-4253, a Novel LRRK2 Inhibitor Targeting Neuroinflammation
Completion of SAD/MAD trial marks advancement toward further clinical development of HT-4253 in Alzheimer’s and other neurodegenerative diseases.
-
Nelson Labs to Double Cleanroom Capacity to Support Growing Demand for Sterility Assurance Services
Strategic Expansion in Salt Lake City Headquarters Will Meet Stringent EU GMP Annex 1 Requirements
-
RATIO THERAPEUTICS AND NUSANO ENTER LONG-TERM, MULTI-ISOTOPE SUPPLY AGREEMENT TO BOOST PRODUCTION OF CANCER RADIOPHARMACEUTICALS
AGREEMENT PROVIDES RATIO ACCESS TO NUSANO-PRODUCED RADIOISOTOPES FOR ONCOLOGY DIAGNOSTICS AND THERAPEUTICS
-
Microvascular Therapeutics announces Founder and CEO Dr. Evan Unger as panelist in Commercializing SBIR/STTR Technologies Discussion at BIO 2025
Microvascular Therapeutics announces Founder and CEO Dr. Evan Unger as panelist in Commercializing SBIR/STTR Technologies Discussion at BIO…
-
Biolexis Therapeutics Advances Breakthrough GLP-1 and AMPK Programs into First-in-Human Clinical Trials
Groundbreaking Preclinical Data Propel Clinical Milestone
-
Rebel Medicine Announces Series A Financing and Investigational New Drug (IND) Application Opening to Advance Non‑Opioid Pain Therapeutic into Clinical Development
Rebel Medicine Announces Series A Financing and Investigational New Drug (IND) Application Opening to Advance Non‑Opioid Pain Therapeutic…
-
NUSANO STABLE ISOTOPE PROGRAM ENRICHES GADOLINIUM-160 TO 99.2% PURITY
DOMESTIC STABLE ISOTOPE PROGRAM KEY TO STABILIZING SUPPLY CHAINS, ENABLING INNOVATION
-
CancerVax Targets Liver Cancers to Further Showcase Flexibility of Its Universal Platform
Using AI machine learning, the Company discovers distinct biomarkers for detecting certain rare liver cancers that have stem…
-
Seek Labs Unveils BioSeeker™
Bioseeker™ is the AI Discovery Engine Powering Seek Labs’ Mission to Outpace Disease with Faster, Smarter Global Health…
-
Halia Therapeutics Completes Enrollment in Phase 2a Clinical Trial of HT-6184 for Myelodysplastic Syndrome (MDS)
Halia Therapeutics Completes Enrollment in Phase 2a Clinical Trial of HT-6184 for Myelodysplastic Syndrome (MDS)
-
Myriad Genetics Announces Early Access to the FirstGene Multiple Prenatal Screen
Screening test provides prenatal risk assessment for common genetic conditions in one blood draw without the need for…
-
Growing collaboration with New York Kidney & Hypertension Medicine
Renalytix collaborates with NYKHM to bring kidneyintelX.dkd testing to underserved communities in the Greater New York area, enabling…
-
CancerVax Scientists Featured on Cytiva’s “Discovery Matters” Podcast Discussing Universal Cancer Vaccine Platform
Dr. George Katibah and Dr. Adam Grant describe the features and progress of the Company’s revolutionary technology
-
Myriad Genetics Highlights New Research Advancements and Oncology Innovations at 2025 ASCO Annual Meeting
Two Molecular Residual Disease (MRD) studies highlighting clinical data among seven new studies to be shared by Myriad…
Call to Action
Post Category
- BioUtah COVID-19 Analysis
- BioUtah News
- Business Tools & Resources
- Call to Action
- COVID-19 Legislation
- COVID-19 Updates
- Economic Developments
- Events
- Events
- Feature
- Featured Members
- Federal News
- Funding
- Funding
- Guests Posts
- HHS/FDA & Other Regulatory
- HR
- Industry News
- Life Sciences Events
- Life Sciences Industry News
- Newsletters
- Non-chair
- Policy News
- Press Releases
- State News
- Utah's Life Sciences Companies
- Workplace Safety
Latest Posts
- Lumea Named Best New Biopsy Technology Solution in 2026 MedTech Breakthrough Awards
- Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
- BlueWind Medical Secures $47.8M Financing to Accelerate Commercialization of Revi® System
- PhotoPharmics Announces Last Patient Last Visit in Pivotal, Phase 3, Light for PD Clinical Trial…
- AFTER SUCCESSFUL FDA MEETING, CLENE FILING ACCELERATED APPROVAL NDA FOR ALS
